NCT05810350 2023-04-13
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
Three Gorges Hospital of Chongqing University
Phase 2 Unknown
Clinical Trials
11 trialsNCT05305885 2022-09-30
Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis
The First Hospital of Jilin University
Phase NA Unknown
NCT05385185 2022-05-23
Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer
Hebei Medical University
Phase 2 Unknown
NCT04944069 2021-06-29
ATTRACT
Second Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT04833205 2021-04-20
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Hebei Medical University
Phase 2 Unknown
NCT04425681 2020-06-11
OWBLM
Second Affiliated Hospital of Nanchang University
Phase 2 Unknown
NCT04356118 2020-05-27
Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Hebei Medical University
Phase 4 Unknown
NCT04148898 2019-11-04
OWONBNSCLCLM
Second Affiliated Hospital of Nanchang University
Phase 2 Unknown
NCT02607605 2017-10-26
ctDNA
Sun Yat-sen University
Unknown
NCT02803619 2016-06-17
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
Peking Union Medical College Hospital
Unknown
NCT01818713 2013-10-29
Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
The Netherlands Cancer Institute
Phase 2 Unknown